Prosecution Insights
Prosecution Insights
3 pending office actions • 2 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready
Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 1 (33%) |
| §103 only | 1 (33%) |
| §102 only | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SITTON, JEHANNE SOUAYA | 1 | 52.9% | +47.9% |
| SALMON, KATHERINE D | 1 | 42.6% | +38.0% |
| CASH, KAILEY ELIZABETH | 1 | 28.6% | +48.9% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17768601 | COMPOSITION FOR DIAGNOSING LIVER CANCER BY USING CPG METHYLATION CHANGES IN SPECIFIC GENES, AND USE THEREOF | CASH, KAILEY ELIZABETH | 100d overdue |
| 17795848 | COMPOSITION USING CPG METHYLATION CHANGES IN SPECIFIC GENES TO DIAGNOSE BLADDER CANCER, AND USE THEREOF | SALMON, KATHERINE D | 47d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17768601 | COMPOSITION FOR DIAGNOSING LIVER CANCER BY USING CPG METHYLATION CHANGES IN SPECIFIC GENES, AND USE THEREOF | CASH, KAILEY ELIZABETH | 100d overdue |
| 18030515 | COMPOSITION FOR DIAGNOSING COLORECTAL CANCER, RECTAL CANCER OR COLORECTAL ADENOMA BY USING CPG METHYLATION CHANGE OF LINC01798 GENE, AND USE THEREOF | SITTON, JEHANNE SOUAYA | 31d overdue |
| 17795848 | COMPOSITION USING CPG METHYLATION CHANGES IN SPECIFIC GENES TO DIAGNOSE BLADDER CANCER, AND USE THEREOF | SALMON, KATHERINE D | 47d |
| Art Unit | Apps |
|---|---|
| 1682 | 2 |
| 1683 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18030515 | COMPOSITION FOR DIAGNOSING COLORECTAL CANCER, RECTAL CANCER OR COLORECTAL ADENOMA BY USING CPG METHYLATION CHANGE OF LINC01798 GENE, AND USE THEREOF | SITTON, JEHANNE SOUAYA | 1682 | §102 | Non-Final OA | 31d overdue | Pending | Apr 06, 2023 |
| 17795848 | COMPOSITION USING CPG METHYLATION CHANGES IN SPECIFIC GENES TO DIAGNOSE BLADDER CANCER, AND USE THEREOF | SALMON, KATHERINE D | 1682 | §101 | Final Rejection | 47d | Pending | Jul 27, 2022 |
| 17768601 | COMPOSITION FOR DIAGNOSING LIVER CANCER BY USING CPG METHYLATION CHANGES IN SPECIFIC GENES, AND USE THEREOF | CASH, KAILEY ELIZABETH | 1683 | §103 | Final Rejection | 100d overdue | Pending | Apr 13, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial